Endowment Managers' Compensation Reported

Harvard Management Company has issued its annual report on the compensation of its highest-earning investment professionals...

Harvard Management Company (HMC) has issued its annual report on the compensation of its most highly paid in-house investment professionals. The news, often the subject of close scrutiny, comes at a particularly sensitive time.

The managers' compensation is heavily performance-based: their base salaries are supplemented by substantial bonuses only if they exceed market rates of return in the asset classes for which they are responsible--and, further, sustain that return over time (if performance subsequently lags, bonuses earned but not yet paid out can be "clawed back"). During fiscal year 2008, which ended last June 30, HMC achieved an 8.6 percent return on endowment assets--much better than the 13.1 percent decline in the Standard & Poor's index of large U.S. stocks and even ahead of the 7.1 percent return on the broadest bond-market proxy. The aggregate return for the fiscal year exceeded market returns of 6.9 percent on HMC's benchmarks for its portfolio overall, yielding an extra "value-added" margin of investment return, worth $600 million to the endowment. During the stellar fiscal 2007 year, HMC's aggregate return was 23 percent: 5.8 percentage points better than market benchmarks, representing extra endowment returns of $1.7 billion.

Those halcyon days--which in fact drive much of this year's bonus awards--are of course overshadowed in memory by the recent sharp decline in the value of Harvard's endowment, and those of all known peer institutions, reflecting the rout in financial markets worldwide since last summer. (Whatever the returns for the current fiscal year turn out to be, they may, of course, be relatively better or worse than the performance of the relevant market benchmarks for HMC's asset classes; that, in turn, will figure into compensation awards for future years.)

According to the news release, these were the five highest-paid employees (figures include salaries, bonuses, and benefits):

Stephen Blyth, $6.4 million, Managing Director--International Fixed Income

Marc Seidner, $6.3 million, Managing Director--Domestic Fixed Income

Stanley Zuzic, $4.9 million, Senior Vice President--Domestic Equities

Steven Alperin, $4.4 million. Managing Director--Emerging Market Equities

Andrew Wiltshire,$3.9 million, Managing Director--Natural Resources

In addition, Mohamed El-Erian, former president and CEO, was paid $921,000. He announced his intention to resign and to return to his previous employer in California, in September 2007, and departed that December. 

For past coverage of HMC compensation, including some explanation of the performance-related bonus system, see also here and here.

 

You might also like

Harvard College Applications Surge 15 Percent

Of 1,648 students in the class of 2030, 39 percent will pay no tuition.

Harvard Law School Announces $31.4 Million Donation

The school’s largest-ever gift comes after a year of record fundraising.

Three Harvard Unions Move Toward Strikes

Dining employees, academic workers unions join graduate students in threatening a walkout.

Most popular

To Promote Healthy Habits in Patients, Start with the Doctors

Why Harvard Medical School is training physicians to think more like coaches

Which Lifestyle Medicine Pillar Suits You?

Take this quiz on six healthy habits that Harvard doctors recommend

Why Do We Still Have the Electoral College?

Historian Alexander Keyssar on why the unpopular institution has prevailed 

Explore More From Current Issue

Colorful illustration of a split-level house showing various activities in different rooms.

Can the College do more to prepare students for the real world?

Bronze statue of a seated figure holding a book, with a campus setting in the background.

As humanities shrink across higher education, one department is flourishing. Is its success a fluke, or a roadmap?

Delicate green cocoa pods and small white flowers on a tree branch, surrounded by soft greenery.

Harvard researchers investigate climate’s impact on cocoa crops, innovations in nasal vaccines, and links between pain and skull marrow.